carvedilol has been researched along with Hypokalemia in 2 studies
Hypokalemia: Abnormally low potassium concentration in the blood. It may result from potassium loss by renal secretion or by the gastrointestinal route, as by vomiting or diarrhea. It may be manifested clinically by neuromuscular disorders ranging from weakness to paralysis, by electrocardiographic abnormalities (depression of the T wave and elevation of the U wave), by renal disease, and by gastrointestinal disorders. (Dorland, 27th ed)
| Excerpt | Relevance | Reference |
|---|
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Robinson, VM | 1 |
| Alsalahat, I | 1 |
| Freeman, S | 1 |
| Antzelevitch, C | 1 |
| Barajas-Martinez, H | 1 |
| Venetucci, L | 1 |
| Coca, SG | 1 |
| Buller, GK | 1 |
2 other studies available for carvedilol and Hypokalemia
| Article | Year |
|---|---|
A carvedilol analogue, VK-II-86, prevents hypokalaemia-induced ventricular arrhythmia through novel multi-channel effects.
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Calcium; Carvedilol; Dantrolene; Dogs; HEK293 Cell | 2022 |
COMET: a proposed mechanism of action to explain the results and concerns about dose.
Topics: Adenosine Triphosphatases; Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Carbazoles; Carvedilol | 2003 |